Subfoveal choroidal neovascularisation Initial PBS authority application Supporting information form (PB072)

You must lodge this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with aflibercept, ranibizumab or verteporfin for the treatment of subfoveal choroidal neovascularisation due to age-related macular degeneration.


Page last updated: 15 June 2016

This information was printed Wednesday 28 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.